Brandon Roses
Physician Assistant • Molalla, OR
861 W Main St
Molalla, OR 970389352
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 28, 2017; this date does not establish years in practice.
-
Published CMS data list 1,233 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 64 prescription fills, including refills.
- Atorvastatin Calcium — 63 prescription fills, including refills.
- Simvastatin — 60 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 47 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in Oregon (2024, 1,336 clinicians with data). Median for this group: 340. Middle half: 96 to 1,131.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 458 in 2020 to 1,233 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
861 W Main St
Molalla, OR 970389352
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,389 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$74,972 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,077.36 across 101 records.
By nature of payment
- Food and Beverage: $2,077.36 across 101 records.
Reporting-company totals (3 largest of 22)
- Pfizer Inc.: $314.04 across 15 records.
- AstraZeneca Pharmaceuticals LP: $287.21 across 13 records.
- ABBVIE INC.: $252.70 across 12 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Brandon Roses has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Brandon Roses as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Molalla and Oregon
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in Oregon (2024, 1,336 clinicians with data). Median for this group: 340. Middle half: 96 to 1,131.
Too few clinicians listed under Physician Assistant in Molalla have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Physician Assistant in Oregon (2024, 1,336 clinicians with data). Median for this group: $8,538. Middle half: $984 to $101,656.
Too few clinicians listed under Physician Assistant in Molalla have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Physician Assistant with a practice address in Molalla, OR (2,095 in Oregon).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 169% from 458 in 2020 to 1,233 in 2024.
- 2020: 458
- 2021: 754
- 2022: 1,072
- 2023: 1,359
- 2024: 1,233
-
30-day fills
30-day fills increased 179% from 858 in 2020 to 2,389 in 2024.
- 2020: 858
- 2021: 1,496
- 2022: 2,112
- 2023: 2,668
- 2024: 2,389
-
Part D drug cost
Part D drug cost increased 1256% from $5,530 in 2020 to $74,972 in 2024.
- 2020: $5,530
- 2021: $12,234
- 2022: $17,277
- 2023: $42,160
- 2024: $74,972
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 68% from $1,238.24 in 2021 to $2,077.36 in 2025.
- 2021: $1,238.24
- 2022: $1,631.83
- 2023: $1,756.55
- 2024: $2,188.99
- 2025: $2,077.36
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 101 records totaling $2,077.36.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $33.08 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $31.90 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $31.25 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $29.43 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $29.27 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $28.55 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $28.53 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $27.45 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $27.23 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PREVNAR 20 | General | $27.17 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PREVNAR 20 | General | $26.69 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $26.63 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $25.78 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $25.43 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PREVNAR 20 | General | $25.03 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $25.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $24.90 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
JOURNAVX | General | $24.59 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $24.53 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
ZEPBOUND | General | $24.25 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $24.06 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $24.03 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $23.75 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $23.39 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $23.35 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 64 | 4,804 | $704.26 | 19 |
| Atorvastatin Calcium | Atorvastatin Calcium | 63 | 5,039 | $605.15 | 19 |
| Simvastatin | Simvastatin | 60 | 4,710 | $562.33 | 20 |
| Amlodipine Besylate | Amlodipine Besylate | 60 | 4,430 | $517.82 | 19 |
| Prednisone | Prednisone | 57 | 329 | $196.45 | 49 |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | 1,832 | $243.37 | 18 |
| Lisinopril | Lisinopril | 44 | 3,730 | $262.03 | 20 |
| Ozempic | Semaglutide | 43 | 1,680 | $50,098.76 | — |
| Levothyroxine Sodium | Levothyroxine Sodium | 42 | 3,490 | $570.85 | 19 |
| Losartan Potassium | Losartan Potassium | 39 | 3,223 | $432.33 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 36 | 2,910 | $582.45 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 245 | $314.39 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | 1,380 | $183.32 | — |
| Potassium Chloride | Potassium Chloride | 32 | 1,910 | $516.48 | 13 |
| Furosemide | Furosemide | 31 | 1,725 | $136.90 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 31 | 2,534 | $709.88 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 29 | 628 | $1,131.46 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | 911 | $647.41 | 20 |
| Azithromycin | Azithromycin | 26 | 147 | $122.71 | 22 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 155 | $333.81 | 23 |
| Cephalexin | Cephalexin | 20 | 255 | $213.52 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 20 | 388 | $151.14 | 14 |
| Metformin Hcl Er | Metformin Hcl | 20 | 1,680 | $144.90 | — |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | 785 | $114.61 | 13 |
| Trazodone Hcl | Trazodone Hcl | 18 | 1,240 | $242.02 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-04-09NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PHYSICIAN ASSISTANT
I20171002003534
OR
8729353792
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 861 W MAIN ST, MOLALLA, OR 970389352 (Tel: 5038745653)
Registered at PO BOX 3417, PORTLAND, OR 972083417 (Tel: 5034133900)
NPI status registered as active in NPPES database
Registered at 18380 WILLAMETTE DR STE 202, WEST LINN, OR 970681200 (Tel: (503) 635-8384)
Registered at 18380 WILLAMETTE DR STE 202, WEST LINN, OR 970681200 (Tel: 5036358384)
Recorded as BRANDON ROSES
Physician Assistant (license number reported to NPPES: OR PA182825)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistants in Molalla
Mailing Address
Po Box 3417
Portland, OR 972083417
Phone: 5034133900